INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ISRG - US46120E6023 - Common Stock
468.2 EUR
-35 (-6.96%)
Overall 1ISRG gets a fundamental rating of 6 out of 10. We evaluated 1ISRG against 67 industry peers in the Health Care Equipment & Supplies industry. 1ISRG gets an excellent profitability rating and is at the same time showing great financial health properties. 1ISRG is valued quite expensive, but it does show an excellent growth. These ratings could make 1ISRG a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
- In the past year 1ISRG was profitable.
- 1ISRG had a positive operating cash flow in the past year.
- Each year in the past 5 years 1ISRG has been profitable.
- In the past 5 years 1ISRG always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 14.19%, 1ISRG belongs to the top of the industry, outperforming 92.54% of the companies in the same industry.
- 1ISRG has a Return On Equity of 16.12%. This is amongst the best in the industry. 1ISRG outperforms 82.09% of its industry peers.
- With an excellent Return On Invested Capital value of 12.45%, 1ISRG belongs to the best of the industry, outperforming 86.57% of the companies in the same industry.
- 1ISRG had an Average Return On Invested Capital over the past 3 years of 10.15%. This is in line with the industry average of 9.84%.
- The 3 year average ROIC (10.15%) for 1ISRG is below the current ROIC(12.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 12.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1.3 Margins
- 1ISRG's Profit Margin of 28.58% is amongst the best of the industry. 1ISRG outperforms 97.01% of its industry peers.
- 1ISRG's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 29.44%, 1ISRG belongs to the top of the industry, outperforming 97.01% of the companies in the same industry.
- 1ISRG's Operating Margin has declined in the last couple of years.
- 1ISRG has a Gross Margin of 66.38%. This is in the better half of the industry: 1ISRG outperforms 71.64% of its industry peers.
- 1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ISRG is still creating some value.
- The number of shares outstanding for 1ISRG has been increased compared to 1 year ago.
- The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
- There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.25
WACC9.99%
2.3 Liquidity
- 1ISRG has a Current Ratio of 4.97. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 4.97, 1ISRG belongs to the top of the industry, outperforming 97.01% of the companies in the same industry.
- 1ISRG has a Quick Ratio of 4.20. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
- 1ISRG has a better Quick ratio (4.20) than 97.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 28.12% over the past year.
- 1ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
- Looking at the last year, 1ISRG shows a very strong growth in Revenue. The Revenue has grown by 22.18%.
- Measured over the past years, 1ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 13.27% on average per year.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
- 1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.67% yearly.
- 1ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.12% yearly.
EPS Next Y20.12%
EPS Next 2Y16.35%
EPS Next 3Y15.9%
EPS Next 5Y15.67%
Revenue Next Year21.33%
Revenue Next 2Y18.13%
Revenue Next 3Y16.56%
Revenue Next 5Y14.12%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 63.18, 1ISRG can be considered very expensive at the moment.
- 62.69% of the companies in the same industry are cheaper than 1ISRG, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 27.38, 1ISRG is valued quite expensively.
- With a Price/Forward Earnings ratio of 54.81, 1ISRG can be considered very expensive at the moment.
- Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than the industry average as 74.63% of the companies are valued more cheaply.
- The average S&P500 Price/Forward Earnings ratio is at 24.29. 1ISRG is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.18 | ||
| Fwd PE | 54.81 |
4.2 Price Multiples
- 1ISRG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 68.66% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ISRG is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 84.89 | ||
| EV/EBITDA | 53.46 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
- 1ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
- 1ISRG's earnings are expected to grow with 15.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.14
PEG (5Y)5.5
EPS Next 2Y16.35%
EPS Next 3Y15.9%
5. Dividend
5.1 Amount
- No dividends for 1ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIT:1ISRG (1/15/2026, 7:00:00 PM)
468.2
-35 (-6.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-21 2025-10-21/amc
Earnings (Next)01-22 2026-01-22/amc
Inst Owners88.29%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap165.98B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts77
Price Target530.96 (13.4%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)1.86%
PT rev (3m)3.44%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)3.26%
EPS NY rev (1m)0.16%
EPS NY rev (3m)5.8%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)1.72%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.18 | ||
| Fwd PE | 54.81 | ||
| P/S | 20.06 | ||
| P/FCF | 84.89 | ||
| P/OCF | 65.13 | ||
| P/B | 11.31 | ||
| P/tB | 11.55 | ||
| EV/EBITDA | 53.46 |
EPS(TTM)7.41
EY1.58%
EPS(NY)8.54
Fwd EY1.82%
FCF(TTM)5.52
FCFY1.18%
OCF(TTM)7.19
OCFY1.54%
SpS23.34
BVpS41.38
TBVpS40.54
PEG (NY)3.14
PEG (5Y)5.5
Graham Number83.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 12.45% | ||
| ROICexc | 24.65% | ||
| ROICexgc | 25.69% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC9.99%
ROIC/WACC1.25
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y20.12%
EPS Next 2Y16.35%
EPS Next 3Y15.9%
EPS Next 5Y15.67%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.33%
Revenue Next 2Y18.13%
Revenue Next 3Y16.56%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year45.96%
EBIT Next 3Y24.75%
EBIT Next 5Y20.85%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / 1ISRG.MI FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 6 / 10 to 1ISRG.MI.
What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for 1ISRG stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 63.18 and the Price/Book (PB) ratio is 11.31.
Can you provide the financial health for 1ISRG stock?
The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 7 / 10.